Ptc Therapeutics (PTCT) Revenue (QoQ) (2012 - 2026)
Powered by 
Analysis
Ptc Therapeutics (PTCT) Revenue (QoQ) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 10 | Ptc Therapeutics | 5.79 Bn | 3.56 Bn | 340.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32.28% |
| Mar 31, 2026 | 65.51% |
| Dec 31, 2025 | -21.96% |
| Sep 30, 2025 | 17.96% |
| Jun 30, 2025 | -84.79% |
| Mar 31, 2025 | 451.71% |
| Dec 31, 2024 | 8.33% |
| Sep 30, 2024 | 5.40% |
| Jun 30, 2024 | -11.14% |
| Mar 31, 2024 | -31.57% |
| Dec 31, 2023 | 56.20% |
| Sep 30, 2023 | -8.06% |
| Jun 30, 2023 | -2.98% |
| Mar 31, 2023 | 31.64% |
| Dec 31, 2022 | -22.90% |
| Sep 30, 2022 | 31.17% |
| Jun 30, 2022 | 11.29% |
| Mar 31, 2022 | -9.98% |
| Dec 31, 2021 | 19.09% |
| Sep 30, 2021 | 18.91% |